When RCC cell lines were treated with a combination of 2-DG and PPARα antagonist (GW6471), the OXPHOS activity levels showed no significant differences compared to the control cells, while GW6471 alone was able to impair oxidative phosphorylation, but not FAO. This evidence concerns the gene PPARA and renal cell carcinoma.